World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 11 September 2017
Main ID:  ChiCTR-INR-17012623
Date of registration: 2017-09-08
Prospective Registration: Yes
Primary sponsor: Eye Center of Second Affiliated hospital of Zhejiang University School of Medicine
Public title: Clinical evaluation of different femtosecond laser fragmentation patterns of the nucleus in cataract surgery
Scientific title: Clinical evaluation of different femtosecond laser fragmentation patterns of the nucleus in cataract surgery
Date of first enrolment: 2017-09-11
Target sample size: 1:60;2:60;3:60;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=20895
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  New Treatment Measure Clinical Study
Countries of recruitment
China
Contacts
Name: Ke Yao   
Address:  88 Jiefang Road, Hangzhou, Zhejiang, China
Telephone: +86 13906517262
Email: xlren@zju.edu.cn
Affiliation:  Eye Center of Second Affiliated hospital of Zhejiang University School of Medicine
Name: Zeren Shen   
Address:  88 Jiefang Road, Hangzhou, Zhejiang, China
Telephone: +86 13732229034
Email: zrshen@zju.edu.cn
Affiliation:  Eye Center of Second Affiliated hospital of Zhejiang University School of Medicine
Key inclusion & exclusion criteria
Inclusion criteria: Male or female patients, 18-90 years of age, with cataract were enrolled. Patients were schedule to undergo femtosecond laser-assisted cataract surgery.
Exclusion criteria: Excluded were patients with allergy to any of the study medications, corneal diseases or ocular infectious disease, history of ocular chemical or thermal burn or any ocular operation, glaucoma or ocular hypertension, history of serious systemic disease, or other conditions that in the opinion of the investigator precluded enrollment. Patients who were initially included were excluded if they had intraoperative or postoperative complications. Women who were pregnant or lactating were not permitted to be in the study.

Age minimum: 18
Age maximum: 90
Gender: Both
Health Condition(s) or Problem(s) studied
cataract
Intervention(s)
1:4-segments Chop Mode;2:6-segments Chop Mode;3:Frag Mode;
Primary Outcome(s)
IOP;UDVA;CDVA;endothelial cell density;central corneal thickness;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
N/A
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history